Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy.

http://www.ncbi.nlm.nih.gov/pubmed/20509084

Some studies report differences in opioid withdrawal between racial/ethnic groups. However, it is not known if these differences are reflected in differential treatment response. Data from National Institute on Drug Abuse (NIDA) Clinical Trials Network-003 were used to examine racial/ethnic differences before and during stabilization with buprenorphine. At induction, non-Hispanic Caucasians had higher objective and subjective withdrawal scores and greater opioid craving than minority participants. No significant between-group differences were observed on these scales following buprenorphine. Non-Hispanic Caucasians and Hispanics reported more adverse events than African Americans. Although ethnic and racial differences were observed prior to buprenorphine treatment, scores following buprenorphine treatment were similar between groups.

Pubmed ID: 20509084 RIS Download

Mesh terms: Adult | African Americans | Buprenorphine | European Continental Ancestry Group | Female | Hispanic Americans | Humans | Male | Middle Aged | Narcotic Antagonists | National Institute on Drug Abuse (U.S.) | Opioid-Related Disorders | Randomized Controlled Trials as Topic | Substance Withdrawal Syndrome | United States | Young Adult